Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Eden

Showing results (201-210 of 286) with videos related to

Pageof 29
Sort By:
Addiction Science & Clinical Practice|April 30, 2023
Preliminary feasibility of integrating tobacco treatment into SUD peer recovery coaching: a mixed-methods study of peer recovery coachesJoanna M Streck, Susan Regan, Michael Werner, et al.
The Journal of Clinical Psychiatry|November 26, 2008
Predictors of early abstinence in smokers with schizophreniaMelissa A Culhane, David A Schoenfeld, Ruth S Barr, et al.
Lancet (London, England)|April 28, 2016
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trialRobert M Anthenelli, Neal L Benowitz, Robert West, et al.
Drug and Alcohol Dependence|July 19, 2011
Association between CHRNA5 genetic variation at rs16969968 and brain reactivity to smoking images in nicotine dependent womenAmy C Janes, Jordan W Smoller, Sean P David, et al.
Acta Psychiatrica Scandinavica|January 21, 2006
Homocysteine levels and glucose metabolism in non-obese, non-diabetic chronic schizophreniaD C Henderson, P M Copeland, D D Nguyen, et al.
Journal of Psychiatric Practice|July 24, 2009
Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapineDavid C Henderson, Xiaoduo Fan, Bikash Sharma, et al.
Drug and Alcohol Dependence|January 13, 2023
Cannabis use and sleep quality in daily life: An electronic daily diary study of adults starting cannabis for health concernsBrenden Tervo-Clemmens, William Schmitt, Grace Wheeler, et al.
Drug and Alcohol Dependence|January 26, 2024
Contingency management is associated with positive changes in attitudes and reductions in cannabis use even after discontinuation of incentives among non-treatment seeking youthMegan E Cooke, Sarah J Knoll, Joanna M Streck, et al.
The Journal of Clinical Psychiatry|February 26, 2008
A randomized, double-blind, placebo-controlled trial of long-acting risperidone in cocaine-dependent menTsafrir Loebl, Gustavo A Angarita, Gladys N Pachas, et al.
Addictive Behaviors|July 10, 2024
Intention to quit or reduce e-cigarettes, cannabis, and their co-use among a school-based sample of adolescentsJessica Liu, Sarah J Knoll, Michael P Pascale, et al.
Pageof 29

Showing results (201-210 of 286) with videos related to

Sort By:
Pageof 29
Addiction Science & Clinical Practice|April 30, 2023
Preliminary feasibility of integrating tobacco treatment into SUD peer recovery coaching: a mixed-methods study of peer recovery coachesJoanna M Streck, Susan Regan, Michael Werner, et al.
The Journal of Clinical Psychiatry|November 26, 2008
Predictors of early abstinence in smokers with schizophreniaMelissa A Culhane, David A Schoenfeld, Ruth S Barr, et al.
Lancet (London, England)|April 28, 2016
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trialRobert M Anthenelli, Neal L Benowitz, Robert West, et al.
Drug and Alcohol Dependence|July 19, 2011
Association between CHRNA5 genetic variation at rs16969968 and brain reactivity to smoking images in nicotine dependent womenAmy C Janes, Jordan W Smoller, Sean P David, et al.
Acta Psychiatrica Scandinavica|January 21, 2006
Homocysteine levels and glucose metabolism in non-obese, non-diabetic chronic schizophreniaD C Henderson, P M Copeland, D D Nguyen, et al.
Journal of Psychiatric Practice|July 24, 2009
Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapineDavid C Henderson, Xiaoduo Fan, Bikash Sharma, et al.
Drug and Alcohol Dependence|January 13, 2023
Cannabis use and sleep quality in daily life: An electronic daily diary study of adults starting cannabis for health concernsBrenden Tervo-Clemmens, William Schmitt, Grace Wheeler, et al.
Drug and Alcohol Dependence|January 26, 2024
Contingency management is associated with positive changes in attitudes and reductions in cannabis use even after discontinuation of incentives among non-treatment seeking youthMegan E Cooke, Sarah J Knoll, Joanna M Streck, et al.
The Journal of Clinical Psychiatry|February 26, 2008
A randomized, double-blind, placebo-controlled trial of long-acting risperidone in cocaine-dependent menTsafrir Loebl, Gustavo A Angarita, Gladys N Pachas, et al.
Addictive Behaviors|July 10, 2024
Intention to quit or reduce e-cigarettes, cannabis, and their co-use among a school-based sample of adolescentsJessica Liu, Sarah J Knoll, Michael P Pascale, et al.
Pageof 29